Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Nicotine for Motor Symptoms in Advanced Parkinson's Disease
NCT00873392Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in Parkinson's disease (PD), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2009; status: completed.
02
Drugs
nicotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00873392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873392.